| pubmed-article:10458228 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10458228 | lifeskim:mentions | umls-concept:C1261473 | lld:lifeskim |
| pubmed-article:10458228 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:10458228 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
| pubmed-article:10458228 | lifeskim:mentions | umls-concept:C0239307 | lld:lifeskim |
| pubmed-article:10458228 | lifeskim:mentions | umls-concept:C0006826 | lld:lifeskim |
| pubmed-article:10458228 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:10458228 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:10458228 | lifeskim:mentions | umls-concept:C0029246 | lld:lifeskim |
| pubmed-article:10458228 | lifeskim:mentions | umls-concept:C0035168 | lld:lifeskim |
| pubmed-article:10458228 | lifeskim:mentions | umls-concept:C0225317 | lld:lifeskim |
| pubmed-article:10458228 | lifeskim:mentions | umls-concept:C1704327 | lld:lifeskim |
| pubmed-article:10458228 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:10458228 | lifeskim:mentions | umls-concept:C1514474 | lld:lifeskim |
| pubmed-article:10458228 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:10458228 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:10458228 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
| pubmed-article:10458228 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:10458228 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:10458228 | pubmed:dateCreated | 1999-9-3 | lld:pubmed |
| pubmed-article:10458228 | pubmed:abstractText | A total of 2,185 patients with advanced soft tissue sarcomas who had been treated in seven clinical trials investigating the use of doxorubicin- or epirubicin-containing regimens as first-line chemotherapy were studied in this prognostic-factor analysis. | lld:pubmed |
| pubmed-article:10458228 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10458228 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10458228 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10458228 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10458228 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10458228 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10458228 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10458228 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:10458228 | pubmed:issn | 0732-183X | lld:pubmed |
| pubmed-article:10458228 | pubmed:author | pubmed-author:OosterhuisJ... | lld:pubmed |
| pubmed-article:10458228 | pubmed:author | pubmed-author:CrowtherDD | lld:pubmed |
| pubmed-article:10458228 | pubmed:author | pubmed-author:TurszTT | lld:pubmed |
| pubmed-article:10458228 | pubmed:author | pubmed-author:SantoroAA | lld:pubmed |
| pubmed-article:10458228 | pubmed:author | pubmed-author:van... | lld:pubmed |
| pubmed-article:10458228 | pubmed:author | pubmed-author:SomersRR | lld:pubmed |
| pubmed-article:10458228 | pubmed:author | pubmed-author:MouridsenHH | lld:pubmed |
| pubmed-article:10458228 | pubmed:author | pubmed-author:VerweijJJ | lld:pubmed |
| pubmed-article:10458228 | pubmed:author | pubmed-author:BuesaJJ | lld:pubmed |
| pubmed-article:10458228 | pubmed:author | pubmed-author:Van... | lld:pubmed |
| pubmed-article:10458228 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10458228 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:10458228 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10458228 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10458228 | pubmed:pagination | 150-7 | lld:pubmed |
| pubmed-article:10458228 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:10458228 | pubmed:meshHeading | pubmed-meshheading:10458228... | lld:pubmed |
| pubmed-article:10458228 | pubmed:meshHeading | pubmed-meshheading:10458228... | lld:pubmed |
| pubmed-article:10458228 | pubmed:meshHeading | pubmed-meshheading:10458228... | lld:pubmed |
| pubmed-article:10458228 | pubmed:meshHeading | pubmed-meshheading:10458228... | lld:pubmed |
| pubmed-article:10458228 | pubmed:meshHeading | pubmed-meshheading:10458228... | lld:pubmed |
| pubmed-article:10458228 | pubmed:meshHeading | pubmed-meshheading:10458228... | lld:pubmed |
| pubmed-article:10458228 | pubmed:meshHeading | pubmed-meshheading:10458228... | lld:pubmed |
| pubmed-article:10458228 | pubmed:meshHeading | pubmed-meshheading:10458228... | lld:pubmed |
| pubmed-article:10458228 | pubmed:meshHeading | pubmed-meshheading:10458228... | lld:pubmed |
| pubmed-article:10458228 | pubmed:meshHeading | pubmed-meshheading:10458228... | lld:pubmed |
| pubmed-article:10458228 | pubmed:meshHeading | pubmed-meshheading:10458228... | lld:pubmed |
| pubmed-article:10458228 | pubmed:meshHeading | pubmed-meshheading:10458228... | lld:pubmed |
| pubmed-article:10458228 | pubmed:meshHeading | pubmed-meshheading:10458228... | lld:pubmed |
| pubmed-article:10458228 | pubmed:meshHeading | pubmed-meshheading:10458228... | lld:pubmed |
| pubmed-article:10458228 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10458228 | pubmed:articleTitle | Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens--a European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study. | lld:pubmed |
| pubmed-article:10458228 | pubmed:affiliation | European Organization for Research and Treatment of Cancer Data Center, Brussels, Belgium. mvg@eortc.be | lld:pubmed |
| pubmed-article:10458228 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10458228 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:10458228 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10458228 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10458228 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10458228 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10458228 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10458228 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10458228 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10458228 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10458228 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10458228 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10458228 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10458228 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10458228 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10458228 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10458228 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10458228 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10458228 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10458228 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10458228 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10458228 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10458228 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10458228 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10458228 | lld:pubmed |
